Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

Open in Screener

STIM

Neuronetics Inc

May 06 • 04:00PM ET

1.91

-0.26 -11.98 %

Healthcare • Medical Devices • USA • Micro • NASD

May 05, 5:41 PMNeuronetics ends Q1 with $19m cash after $5m debt prepayment, maintains second-half 2026 cash-flow positivity target

Peers: COHR NOVA NVCR GNFT XFOR XERS SENS BLDR CANF

| Held by: VTI IWM PSIL IWO VXF VTWO IWC QQQS VTWG RSSL

Index	RUT	P/E	-	EPS (ttm)	-0.55	Insider Own	62.97%	Shs Outstand	69.58M	Perf Week	12.35%
Market Cap	132.91M	Forward P/E	-	EPS next Y	-0.30	Insider Trans	6.85%	Shs Float	25.76M	Perf Month	20.89%
Enterprise Value	202.87M	PEG	-	EPS next Q	-0.12	Inst Own	35.16%	Short Float	42.36%	Perf Quarter	23.23%
Income	-37.11M	P/S	0.88	EPS this Y	22.80%	Inst Trans	6.50%	Short Ratio	4.50	Perf Half Y	-31.05%
Sales	151.64M	P/B	10.02	EPS next Y	33.53%	ROA	-27.76%	Short Interest	10.91M	Perf YTD	38.41%
Book/sh	0.19	P/C	6.92	EPS next 5Y	32.68%	ROE	-152.36%	52W High	4.85 -60.61%	Perf Year	-57.56%
Cash/sh	0.28	P/FCF	-	EPS past 3/5Y	24.64% 16.51%	ROIC	-39.81%	52W Low	0.80 138.75%	Perf 3Y	-15.86%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	31.76% 24.81%	Gross Margin	46.03%	Volatility	14.26% 10.87%	Perf 5Y	-85.48%
Dividend TTM	-	EV/Sales	1.34	EPS Y/Y TTM	58.15%	Oper. Margin	-19.40%	ATR (14)	0.19	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	1.50	Sales Y/Y TTM	69.52%	Profit Margin	-24.48%	RSI (14)	59.57	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	1.67	EPS Q/Q	24.83%	SMA20	16.14%	Beta	1.14	Target Price	4.33
Payout	-	Debt/Eq	6.43	Sales Q/Q	7.75%	SMA50	27.98%	Rel Volume	1.00	Prev Close	2.17
Employees	658	LT Debt/Eq	6.03	Earnings	May 05 BMO	SMA200	-14.81%	Avg Volume	2.43M	Price	1.91
IPO	Jun 28, 2018	Option/Short	Yes / Yes	EPS/Sales Surpr.	8.20% 0.84%	Trades		Volume	2,414,691	Change	-11.98%

Date	Action	Analyst	Rating Change	Price Target Change
Aug-13-24	Downgrade	William Blair	Outperform → Mkt Perform
Oct-13-21	Downgrade	William Blair	Outperform → Mkt Perform
Oct-13-21	Downgrade	BTIG Research	Buy → Neutral
Jan-22-21	Upgrade	William Blair	Mkt Perform → Outperform
Feb-06-20	Initiated	BTIG Research	Buy	$11
Jul-24-18	Initiated	Canaccord Genuity	Buy

May-05-26 04:55PM	Neuronetics, Inc. Q1 2026 Earnings Call Summary (Moby) +7.43% -11.98%
07:57AM	Neuronetics: Q1 Earnings Snapshot (Associated Press)
07:50AM	Neuronetics Reports First Quarter 2026 Financial and Operating Results (GlobeNewswire)
Apr-29-26 04:30PM	Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire) +14.12%
Apr-21-26 08:30AM	Neuronetics to Report First Quarter 2026 Financial and Operating Results and Host Conference Call (GlobeNewswire) -5.06%
08:32AM	Loading…
Apr-13-26 08:32AM	Optum/United Healthcare/United Behavioral Health Expands NeuroStar TMS Coverage to Include Psychiatric Mental Health Nurse Practitioners (GlobeNewswire)
Apr-07-26 07:00AM	Neuronetics Comments on Letter from Pointillist Family Office (GlobeNewswire) -10.23%
Apr-06-26 04:30PM	Neuronetics Announces Chief Financial Officer Transition (GlobeNewswire) +15.79%
04:05PM	Largest Independent Shareholder of Neuronetics, Inc., Jorey Chernett, Calls for Immediate and Comprehensive Review of Strategic Alternatives, Including Sale of TMS Business (PR Newswire)
Mar-17-26 12:46PM	Neuronetics, Inc. Q4 2025 Earnings Call Summary (Moby) -9.93%
08:17AM	Neuronetics: Q4 Earnings Snapshot (Associated Press Finance)
07:50AM	Neuronetics Reports Fourth Quarter and Full Year 2025 Financial and Operating Results (GlobeNewswire)
07:45AM	Neuronetics Appoints Dan Reuvers as President and Chief Executive Officer (GlobeNewswire)
Mar-03-26 08:30AM	Neuronetics to Report Fourth Quarter 2025 Financial and Operating Results and Host Conference Call (GlobeNewswire)
Feb-11-26 12:20AM	Neuronetics (STIM) Stock Rises 41% After Hours: What's Going On? (Benzinga) +23.29%
04:34PM	Loading…
Feb-10-26 04:34PM	Neuronetics Announces Selected Preliminary Unaudited Fourth Quarter and Full Year 2025 Financial Results (GlobeNewswire)
Nov-20-25 08:30AM	Neuronetics to Participate at the Piper Sandler 37th Annual Healthcare Conference (GlobeNewswire) -12.75%
Nov-12-25 10:33AM	TRICARE West Expands NeuroStar TMS Coverage to Include Adolescents Aged 15+ Struggling with Depression (GlobeNewswire)
Nov-04-25 04:08PM	Neuronetics Inc (STIM) Q3 2025 Earnings Call Highlights: Revenue Surges Amid Strategic Acquisitions (GuruFocus.com)
08:40AM	Neuronetics (STIM) Reports Q3 Loss, Misses Revenue Estimates (Zacks)
07:39AM	Neuronetics: Q3 Earnings Snapshot (Associated Press Finance)
07:05AM	Neuronetics Reports Third Quarter 2025 Financial and Operating Results and Announces CEO Transition Plan (GlobeNewswire)
Nov-03-25 08:09AM	Neuronetics Inc (STIM) Q3 2025: Everything You Need To Know Ahead Of Earnings (GuruFocus.com)
Oct-31-25 04:30PM	Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
Oct-30-25 08:32AM	Neuronetics Announces Three-Year Exclusive Partnership with Elite DNA Behavioral Health to Expand NeuroStar Access and Operational Excellence (GlobeNewswire) -6.90%
Oct-21-25 08:30AM	Neuronetics to Report Third Quarter 2025 Financial and Operating Results and Host Conference Call (GlobeNewswire) +5.49%
Sep-17-25 08:32AM	New York State Medicaid Expands Coverage for TMS Therapy, Including NeuroStar Advanced Therapy, to Treat Major Depressive Disorder (MDD) (GlobeNewswire)
Sep-02-25 03:49AM	Neuronetics, Inc. (STIM) Positions as Neurohealth Leader with Adolescent Breakthrough (Insider Monkey) -5.71%
Aug-06-25 04:45PM	Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire) -6.60% -5.65%
Aug-05-25 08:20AM	Neuronetics (STIM) Reports Q2 Loss, Tops Revenue Estimates (Zacks)
07:19AM	Loading…
07:19AM	Neuronetics: Q2 Earnings Snapshot (Associated Press Finance)
07:05AM	Neuronetics Reports Second Quarter 2025 Financial and Operating Results (GlobeNewswire)
Aug-04-25 04:30PM	Neuronetics to Present at the Canaccord Genuity 45th Annual Growth Conference (GlobeNewswire) +5.43%
10:04AM	What To Expect From Neuronetics Inc (STIM) Q2 2025 Earnings (GuruFocus.com)
Jul-30-25 08:32AM	NeuroStar Announces New Publication in JAACAP Open Highlighting Treatment Efficacy in Depressed Adolescents (GlobeNewswire)
Jul-22-25 08:30AM	Neuronetics to Report Second Quarter 2025 Financial and Operating Results and Host Conference Call (GlobeNewswire) +8.76%
Jul-15-25 07:30AM	Neuronetics Appoints New Chief Financial Officer (GlobeNewswire)
Jul-09-25 07:20AM	Neuronetics Showcases NeuroStar TMS Data at Clinical TMS Meeting (Insider Monkey)
Jun-19-25 07:00PM	Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
Jun-10-25 08:31AM	Neuronetics Announces Clinical Presence at the 2025 Clinical TMS Society Annual Meeting and Progress in Greenbrook's Personalized Care Trial Program (GlobeNewswire)
Jun-02-25 04:30PM	Neuronetics Set to Join Russell 2000 and Russell 3000 Indexes (GlobeNewswire)
May-14-25 08:31AM	Neuronetics Launches First Inaugural National TMS Therapy Awareness Day During Mental Health Awareness Month (GlobeNewswire)
May-07-25 03:09AM	Neuronetics Inc (STIM) Q1 2025 Earnings Call Highlights: Revenue Surge Amidst Margin Challenges (GuruFocus.com)
May-06-25 08:20AM	Neuronetics (STIM) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
07:20AM	Neuronetics: Q1 Earnings Snapshot (Associated Press Finance)
07:10AM	Neuronetics Reports First Quarter 2025 Financial and Operating Results (GlobeNewswire)
May-05-25 04:30PM	Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
07:40AM	Integra LifeSciences (IART) Q1 Earnings Miss Estimates (Zacks)
Apr-30-25 05:50AM	Why Neuronetics, Inc. (STIM) is Surging in 2025 (Insider Monkey)
Apr-22-25 08:30AM	Neuronetics to Report First Quarter 2025 Financial and Operating Results and Host Conference Call (GlobeNewswire)
Apr-02-25 03:26PM	BrainsWay: Strong Growth Prospects Matter Little To The Market (Seeking Alpha)
Mar-31-25 08:31AM	Evernorth Health Services, a Cigna Company, Expands NeuroStar TMS Coverage for Adolescents Struggling with Depression (GlobeNewswire)
Mar-29-25 11:45PM	Neuronetics: Explosive Growth Poised To Soar On FDA Breakthroughs (Seeking Alpha)
Mar-27-25 04:30PM	Neuronetics Reports Updated Fourth Quarter and Full Year 2024 Financial and Operating Results (GlobeNewswire) -5.75%
Mar-18-25 09:55AM	Wall Street Analysts Think Neuronetics (STIM) Could Surge 34.98%: Read This Before Placing a Bet (Zacks)
Mar-05-25 02:06AM	Neuronetics Inc (STIM) Q4 2024 Earnings Call Highlights: Revenue Growth Amidst Rising Expenses ... (GuruFocus.com) +7.11%
Mar-04-25 11:29PM	Q4 2024 Neuronetics Inc Earnings Call (Thomson Reuters StreetEvents) +18.78%
07:36AM	Neuronetics: Q4 Earnings Snapshot (Associated Press Finance)
07:10AM	Neuronetics Reports Fourth Quarter and Full Year 2024 Financial and Operating Results (GlobeNewswire)
Mar-03-25 04:30PM	Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
07:20AM	Neuronetics Inc (STIM) Q4 2024 Earnings Report Preview: What To Look For (GuruFocus.com)
Feb-22-25 05:08PM	Neuronetics, Inc. (STIM): Among the Hot Penny Stocks to Buy Now (Insider Monkey)
Feb-21-25 08:30AM	Neuronetics to Report Fourth Quarter 2024 Financial and Operating Results and Host Conference Call (GlobeNewswire) -13.96%
Feb-07-25 04:30PM	Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire) -13.76% +25.73%
07:54AM	Neuronetics Announces Pricing of $18 Million Underwritten Public Offering of Common Stock (GlobeNewswire)
Feb-06-25 04:23PM	Neuronetics Announces Launch of Underwritten Public Offering of Common Stock (GlobeNewswire) +8.87%
Feb-03-25 07:27PM	Why Neuronetics Inc (STIM) Is Skyrocketing So Far In 2025 (Insider Monkey) +7.81%
Jan-29-25 08:31AM	NeuroStar Unveils Two Significant Publications on TMS Therapy for Depression (GlobeNewswire) +6.31%
Jan-13-25 08:00AM	Neuronetics Provides Business Update and Issues 2025 Guidance (GlobeNewswire) +36.84%
Dec-18-24 04:30PM	Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire) +5.38% -5.84%
Dec-16-24 04:30PM	Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire) +19.27%
Dec-10-24 10:00AM	Neuronetics and Greenbrook TMS Announce Closing of Transaction (GlobeNewswire)
Nov-20-24 08:30AM	Neuronetics to Present at the Piper Sandler 36th Annual Healthcare Conference (GlobeNewswire) +6.26%
Nov-13-24 02:10AM	Neuronetics Inc (STIM) Q3 2024 Earnings Call Highlights: Revenue Growth Amid Rising Expenses ... (GuruFocus.com) -11.65%
Nov-12-24 06:45PM	CORRECTION Neuronetics Reports Record Third Quarter 2024 Financial and Operating Results (GlobeNewswire) -37.27%
04:30PM	Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
08:20AM	Neuronetics (STIM) Reports Q3 Loss, Lags Revenue Estimates (Zacks)
07:19AM	Neuronetics: Q3 Earnings Snapshot (Associated Press Finance)
07:10AM	Neuronetics Reports Record Third Quarter 2024 Financial and Operating Results (GlobeNewswire)
Nov-11-24 07:26AM	Neuronetics Inc (STIM) Q3 2024 Earnings Report Preview: What to Expect (GuruFocus.com) -5.98%
Oct-29-24 04:30PM	Neuronetics to Report Third Quarter 2024 Financial and Operating Results and Host Conference Call (GlobeNewswire) +5.94%
Oct-14-24 08:31AM	NeuroStar Oral Presentation at AACAP 2024 Highlights Largest Study Evaluating TMS Efficacy in Adolescents with Depression (GlobeNewswire)
Oct-04-24 08:33AM	Neuronetics and Greenbrook TMS Announce Receipt of Interim Order in Respect of Proposed Arrangement and Provide Details of Shareholder Meetings (PR Newswire) +7.58%
Sep-25-24 08:31AM	Health Care Service Corporation Adds First-Line TMS Coverage for Adolescents (GlobeNewswire) -6.18%
Sep-19-24 08:31AM	Expanded Health Policies Enhance TMS Therapy Access for Adolescents and Adults (GlobeNewswire)
Sep-16-24 08:32AM	NeuroStar Releases Software Upgrades to Elevate Patient Care (GlobeNewswire) +6.70%
Sep-03-24 08:29AM	NeuroStar Honors Suicide Prevention Month With Milestone Achievement and Powerful Stories (GlobeNewswire)
Aug-20-24 08:29AM	NeuroStar Marks Two Years of Transformative Impact with NeuroStar University (GlobeNewswire)
Aug-15-24 05:42AM	Neuronetics inks Greenbrook merger to acquire treatment centers (MedTech Dive) +16.32%
Aug-13-24 12:56PM	Neuronetics' (STIM) Latest Deal to Aid Mental Health Treatments (Zacks)
12:47PM	Neuronetics (STIM) Inks a New Merger Agreement With Greenbrook (Zacks)
09:45AM	Neuronetics (STIM) Q2 Loss Wider Than Expected, Revenues Fall Y/Y (Zacks)
Aug-12-24 08:25AM	Neuronetics (STIM) Reports Q2 Loss, Lags Revenue Estimates (Zacks) -58.15%
07:19AM	Neuronetics: Q2 Earnings Snapshot (Associated Press Finance)
07:15AM	Neuronetics and Greenbrook TMS Announce Definitive Agreement to Merge (GlobeNewswire)
07:10AM	Neuronetics Reports Record Second Quarter 2024 Financial and Operating Results (GlobeNewswire)
Aug-05-24 04:36PM	Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
Aug-01-24 08:29AM	NeuroStar Partners With This Is My Brave to Recognize Teen Mental Health Month (GlobeNewswire)
Jul-31-24 08:30AM	Neuronetics to Present at the Canaccord Genuity 44th Annual Growth Conference (GlobeNewswire)
Jul-30-24 08:30AM	Neuronetics Announces the Closing of up to $90 Million Senior Secured Credit Facility with Perceptive Advisors (GlobeNewswire)

Neuronetics, Inc. is a commercial stage medical technology company, which focuses on designing, developing and marketing products that improve the quality of life for patients who suffer from neurohealth disorders. It operates through United States and International geographical segments. The company was founded by Steven B. Waite, Bruce J. Shook, Norman R. Weldon, and Thomas D. Weldon in 2003 and is headquartered in Malvern, PA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Chernett Jorey	10% Owner	Apr 20 '26	Buy	1.58	100,000	158,000	9,878,988	Apr 22 09:39 AM
Chernett Jorey	10% Owner	Apr 21 '26	Buy	1.51	100,000	151,000	9,978,988	Apr 22 09:39 AM
Chernett Jorey	10% Owner	Mar 30 '26	Buy	1.25	385,442	481,802	9,778,988	Mar 30 07:41 PM
Chernett Jorey	10% Owner	Mar 27 '26	Buy	1.35	500,000	675,000	9,393,276	Mar 30 09:37 AM
Chernett Jorey	10% Owner	Mar 25 '26	Buy	1.40	125,000	175,000	8,868,276	Mar 27 09:33 AM
Chernett Jorey	10% Owner	Mar 26 '26	Buy	1.44	25,000	36,000	8,893,276	Mar 27 09:33 AM
Pfanstiel Steven	EVP, CFO and Treasurer	Mar 19 '26	Sale	1.34	16,431	22,018	828,781	Mar 24 05:52 PM
Sullivan Keith J	Former Officer & Director	Mar 19 '26	Sale	1.34	46,289	62,027	1,590,924	Mar 24 05:50 PM
MACAN WILLIAM ANDREW	EVP, CLO and CS	Mar 19 '26	Sale	1.34	16,005	21,447	897,270	Mar 24 05:48 PM
Chernett Jorey	10% Owner	Mar 20 '26	Buy	1.41	169,472	238,956	8,743,276	Mar 23 09:34 AM
Chernett Jorey	10% Owner	Mar 18 '26	Buy	1.35	607,400	819,990	8,123,804	Mar 20 08:51 AM
Chernett Jorey	10% Owner	Mar 19 '26	Buy	1.33	450,000	598,500	8,573,804	Mar 20 08:51 AM
MACAN WILLIAM ANDREW	Officer	Mar 19 '26	Proposed Sale	1.32	16,005	21,123		Mar 19 04:36 PM
Sullivan Keith J	Officer	Mar 19 '26	Proposed Sale	1.32	46,289	61,092		Mar 19 04:25 PM
Chernett Jorey	10% Owner	Mar 17 '26	Buy	1.16	531,000	615,960	7,516,404	Mar 18 10:36 AM
MACAN WILLIAM ANDREW	EVP, CLO and CS	Mar 04 '26	Sale	1.34	609	816	879,525	Mar 06 04:29 PM
MACAN WILLIAM ANDREW	Officer	Mar 04 '26	Proposed Sale	1.34	609	814		Mar 04 03:09 PM
MACAN WILLIAM ANDREW	EVP, CLO and CS	Feb 26 '26	Sale	1.35	3,427	4,626	880,134	Feb 27 04:34 PM
Sullivan Keith J	President and CEO	Feb 26 '26	Sale	1.35	8,452	11,410	1,524,713	Feb 27 04:33 PM
Sullivan Keith J	Officer	Feb 26 '26	Proposed Sale	1.34	8,452	11,366		Feb 26 03:33 PM
MACAN WILLIAM ANDREW	Officer	Feb 26 '26	Proposed Sale	1.34	3,427	4,609		Feb 26 03:16 PM
Sullivan Keith J	President and CEO	Feb 12 '26	Sale	1.65	33,847	55,848	1,533,165	Feb 18 05:44 PM
MACAN WILLIAM ANDREW	EVP, CLO and CS	Feb 12 '26	Sale	1.65	14,120	23,298	673,561	Feb 18 05:42 PM
MACAN WILLIAM ANDREW	EVP, CLO and CS	Feb 10 '26	Sale	1.55	3,485	5,402	687,681	Feb 12 04:32 PM
Sullivan Keith J	President and CEO	Feb 10 '26	Sale	1.55	40,976	63,513	1,567,012	Feb 12 04:31 PM
Sullivan Keith J	Officer	Feb 12 '26	Proposed Sale	1.65	33,847	55,712		Feb 12 03:19 PM
MACAN WILLIAM ANDREW	Officer	Feb 12 '26	Proposed Sale	1.65	14,120	23,242		Feb 12 03:12 PM
MACAN WILLIAM ANDREW	Officer	Feb 10 '26	Proposed Sale	1.55	3,485	5,392		Feb 10 04:28 PM
Sullivan Keith J	Officer	Feb 10 '26	Proposed Sale	1.55	40,976	63,398		Feb 10 04:14 PM
Madryn Asset Management, LP	10% Owner	Aug 08 '25	Sale	3.72	3,500,000	13,020,000	1,142,351	Aug 12 04:15 PM
MADRYN HEALTH PRTS II (CAY MAS	10% Owner	Aug 08 '25	Proposed Sale	3.72	2,925,554	10,883,061		Aug 08 04:55 PM
MADRYN HEALTH PARTNERS II, LP	10% Owner	Aug 08 '25	Proposed Sale	3.72	192,806	717,238		Aug 08 04:54 PM
MADRYN SELECT OPPORTUNITIES, L	10% Owner	Aug 08 '25	Proposed Sale	3.72	381,640	1,419,701		Aug 08 04:54 PM
Furlong Stephen	Officer	Aug 07 '25	Proposed Sale	4.09	98,635	403,385		Aug 07 04:52 PM
Furlong Stephen	EVP, CFO and Treasurer	May 12 '25	Sale	4.27	193,460	826,074	416,593	May 14 05:05 PM
Furlong Stephen	EVP, CFO and Treasurer	May 13 '25	Sale	4.16	6,540	27,206	410,053	May 14 05:05 PM
Furlong Stephen	Officer	May 13 '25	Proposed Sale	4.16	6,540	27,190		May 13 12:54 PM
Furlong Stephen	Officer	May 12 '25	Proposed Sale	4.27	193,460	826,283		May 12 04:40 PM

KRMD KORU Medical Systems Inc daily Stock Chart

Peers: TMO BDX ABT SYK BAX BSX ZBH CAH HOLX STE

| Held by: VTI IWM VXF IWO VTWO IWC GSSC VTWG RSSL VTHR

Index	RUT	P/E	-	EPS (ttm)	-0.06	Insider Own	7.77%	Shs Outstand	46.37M	Perf Week	1.01%
Market Cap	190.44M	Forward P/E	120.57	EPS next Y	0.03	Insider Trans	0.00%	Shs Float	43.80M	Perf Month	-5.42%
Enterprise Value	185.07M	PEG	-	EPS next Q	-0.02	Inst Own	55.01%	Short Float	1.68%	Perf Quarter	-21.22%
Income	-2.64M	P/S	4.63	EPS this Y	38.27%	Inst Trans	0.99%	Short Ratio	4.80	Perf Half Y	4.43%
Sales	41.13M	P/B	10.91	EPS next Y	189.79%	ROA	-9.09%	Short Interest	0.74M	Perf YTD	-30.98%
Book/sh	0.37	P/C	21.47	EPS next 5Y	-	ROE	-15.58%	52W High	6.61 -39.32%	Perf Year	46.35%
Cash/sh	0.19	P/FCF	-	EPS past 3/5Y	33.31% -14.59%	ROIC	-13.19%	52W Low	2.62 52.76%	Perf 3Y	0.00%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	13.81% 11.21%	Gross Margin	60.28%	Volatility	3.79% 4.68%	Perf 5Y	14.57%
Dividend TTM	-	EV/Sales	4.50	EPS Y/Y TTM	56.80%	Oper. Margin	-7.23%	ATR (14)	0.18	Perf 10Y	1013.89%
Dividend Ex-Date	-	Quick Ratio	1.99	Sales Y/Y TTM	22.23%	Profit Margin	-6.41%	RSI (14)	42.91	Recom	1.40
Dividend Gr. 3/5Y	- -	Current Ratio	2.44	EPS Q/Q	69.12%	SMA20	-2.87%	Beta	0.43	Target Price	6.80
Payout	-	Debt/Eq	0.21	Sales Q/Q	23.27%	SMA50	-7.27%	Rel Volume	0.86	Prev Close	4.08
Employees	73	LT Debt/Eq	0.17	Earnings	May 06 AMC	SMA200	-11.74%	Avg Volume	153.61K	Price	4.01
IPO	Apr 05, 1994	Option/Short	Yes / Yes	EPS/Sales Surpr.	0.00% 4.26%	Trades		Volume	158,341	Change	-1.72%

Date	Action	Analyst	Rating Change	Price Target Change
Feb-14-25	Downgrade	Piper Sandler	Overweight → Neutral	$4.50
Jul-25-24	Resumed	B. Riley Securities	Buy	$4
Sep-07-23	Initiated	Lake Street	Buy	$4
Sep-07-23	Initiated	B. Riley Securities	Buy	$4.50
Nov-10-22	Upgrade	Piper Sandler	Neutral → Overweight	$3 → $3.50
Nov-10-22	Upgrade	Canaccord Genuity	Hold → Buy	$3 → $4
Jan-26-21	Downgrade	Piper Sandler	Overweight → Neutral	$9 → $4.50
Jan-26-21	Downgrade	Canaccord Genuity	Buy → Hold	$5
Aug-10-20	Initiated	H.C. Wainwright	Buy	$16
Jul-16-20	Initiated	Canaccord Genuity	Buy	$13
Jun-24-20	Initiated	Piper Sandler	Overweight	$12

Show Previous Ratings

May-06-26 04:05PM	KORU Medical Systems Announces First Quarter 2026 Results (Business Wire)
Apr-16-26 08:00AM	KORU Medical Systems to Report First Quarter 2026 Financial Results on May 6, 2026 (Business Wire)
Mar-13-26 08:30AM	KORU Medical Systems, Inc. Q4 2025 Earnings Call Summary (Moby)
08:00AM	KORU Medical Systems Announces EU MDR Certification for the Freedom60 Infusion Pump With Prefilled Syringe Compatibility (Business Wire)
Mar-12-26 11:06PM	KORU Medical Systems Inc (KRMD) Q4 2025 Earnings Call Highlights: Strong Revenue Growth and ... (GuruFocus.com)
04:08PM	Loading…
04:08PM	KORU Medical Systems Announces CEO Transition (Business Wire)
04:05PM	KORU Medical Systems Announces +20% Fourth Quarter and Full Year 2025 Revenue Growth, Positive Adjusted EBITDA and Initiates Full Year 2026 Guidance (Business Wire)
Mar-11-26 09:27AM	KORU Medical Systems Inc (KRMD) Q4 2025 Earnings Report Preview: What To Look For (GuruFocus.com)
Feb-26-26 04:05PM	KORU Medical Systems to Report Fourth Quarter and Full Year 2025 Financial Results on March 12, 2026 (Business Wire)
Feb-24-26 09:55PM	Evolent Health (EVH) Q4 Earnings Top Estimates (Zacks)
Feb-12-26 09:35AM	Down 18.1% in 4 Weeks, Here's Why KORU Medical Systems, Inc. (KRMD) Looks Ripe for a Turnaround (Zacks)
Feb-11-26 05:15PM	Inspire Medical Systems (INSP) Beats Q4 Earnings and Revenue Estimates (Zacks)
Feb-03-26 07:13AM	KORU Medical Systems, Inc. (KRMD) Soars 5.6%: Is Further Upside Left in the Stock? (Zacks)
Jan-30-26 07:01AM	KORU Medical receives FDA clearance for FreedomEDGE infusion system (Medical Device Network)
Jan-29-26 04:05PM	KORU Medical Systems Receives FDA 510(k) Clearance for Delivery of RYSTIGGO (rozanolixizumab-noli), Expanding Label for FreedomEDGE Infusion System (Business Wire)
12:00PM	Loading…
Jan-21-26 12:00PM	All You Need to Know About KORU Medical Systems, Inc. (KRMD) Rating Upgrade to Buy (Zacks)
Jan-12-26 08:00AM	KORU Medical Systems Reports Preliminary Q4 and Full Year 2025 Results; Achieves Record Revenue and Full Year Positive Operating Cash Flow (Business Wire)
Jan-09-26 09:18AM	3 MedTech Stocks That Crushed the S&P 500 Over the Past Year (Zacks)
Jan-07-26 12:24PM	BFLY to Extend 3D Imaging Capabilities to Butterfly Garden Developers (Zacks)
Jan-05-26 07:00AM	KORU Medical Systems Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) (Business Wire)
Dec-31-25 10:30AM	KRMD Submits 510(k) to Use FreedomEDGE System With Oncology Biologic (Zacks)
Dec-30-25 04:05PM	KORU Medical Systems Announces 510(k) Submission for Clearance of the FreedomEDGE System with a Commercialized Oncology Biologic (Business Wire) -6.11%
Dec-22-25 07:51AM	Here's Why You Should Retain INSP Stock in Your Portfolio Now (Zacks)
Dec-19-25 08:41AM	Revvity Advances AI-Driven Scientific Discovery With Signals Xynthetica (Zacks)
Dec-18-25 08:28AM	Here's Why You Should Retain CLOV Stock in Your Portfolio Now (Zacks)
Dec-16-25 04:05PM	KORU Medical Systems, Inc. Appoints Eric Schiller as Chief Technology Officer (Business Wire)
Nov-17-25 04:05PM	KORU Medical Systems to Present Promising Results on the Use of the FreedomEDGE Syringe Infusion System in Infusion Centers at ESID/EHA/SIOPE Focused Symposium 2025 (Business Wire)
Nov-13-25 08:00AM	KORU Medical Systems to Participate in Upcoming Investor Conferences (Business Wire) +15.08%
12:02AM	KORU Medical Systems Inc (KRMD) Q3 2025 Earnings Call Highlights: Strong Revenue Growth Amid ... (GuruFocus.com)
Nov-12-25 06:00PM	KORU Medical Systems, Inc. (KRMD) Reports Q3 Loss, Tops Revenue Estimates (Zacks)
04:05PM	Loading…
04:05PM	KORU Medical Systems Announces 27% Q3 Revenue Growth and Raises 2025 Revenue Guidance (Business Wire)
Nov-11-25 07:32AM	KORU Medical Systems Inc (KRMD) Q3 2025: Everything You Need To Know Ahead Of Earnings (GuruFocus.com)
Nov-07-25 07:15AM	Claritev Corporation (CTEV) Reports Q3 Loss, Tops Revenue Estimates (Zacks)
Nov-04-25 04:05PM	KORU Medical Systems Announces Development Agreement for Innovation in Subcutaneous Immunoglobulin Infusion Systems (Business Wire)
Oct-22-25 04:05PM	KORU Medical Systems to Report Third Quarter 2025 Financial Results on November 12, 2025 (Business Wire)
Sep-18-25 08:00AM	ForCast Orthopedics and KORU Medical Systems Announce Agreement for Novel Antibiotic Infusion Therapy (Business Wire)
Aug-28-25 12:00PM	Are You Looking for a Top Momentum Pick? Why KORU Medical Systems, Inc. (KRMD) is a Great Choice (Zacks)
Aug-06-25 06:40PM	KORU Medical Systems, Inc. (KRMD) Reports Break-Even Earnings for Q2 (Zacks) +18.71%
04:05PM	KORU Medical Systems Announces Q2 2025 Financial Results, Including Record Double-digit Revenue, and Raises 2025 Revenue Guidance (Business Wire)
Aug-05-25 07:05PM	American Well Corporation (AMWL) Reports Q2 Loss, Beats Revenue Estimates (Zacks)
10:29AM	KORU Medical Systems Inc (KRMD) Q2 2025 Earnings Report Preview: What To Expect (GuruFocus.com)
Aug-01-25 04:55PM	KORU Medical Systems Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) (Business Wire)
Jul-31-25 07:45AM	Omnicell (OMCL) Beats Q2 Earnings and Revenue Estimates (Zacks)
Jul-30-25 04:05PM	KORU Medical Systems to Participate in the Canaccord Genuity 45th Annual Growth Conference (Business Wire)
Jul-16-25 04:05PM	KORU Medical Systems to Report Second Quarter 2025 Financial Results on August 6, 2025 (Business Wire) +6.46% +5.43%
Jul-07-25 04:05PM	KORU Medical Systems Appoints Adam Kalbermatten as Chief Commercial Officer (Business Wire)
Jun-11-25 04:05PM	KORU Medical Systems to Join Russell 3000 and Russell 2000 Indexes (Business Wire)
May-08-25 03:32AM	KORU Medical Systems Inc (KRMD) Q1 2025 Earnings Call Highlights: Record Revenue and Strategic ... (GuruFocus.com) +20.96%
May-07-25 05:50PM	KORU Medical Systems Inc. (KRMD) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
04:05PM	KORU Medical Systems Announces Record Q1 2025 Financial Results and Raises 2025 Revenue Guidance (Business Wire)
Apr-16-25 04:05PM	KORU Medical Systems to Report First Quarter 2025 Financial Results on May 7, 2025 (Business Wire)
Mar-13-25 03:08AM	KORU Medical Systems Inc (KRMD) Q4 2024 Earnings Call Highlights: Record Revenues and Strategic ... (GuruFocus.com) -17.68%
Mar-12-25 04:05PM	KORU Medical Systems Announces Fourth Quarter and Full Year 2024 Financial Results With Record Revenues and Gross Profit; Issues Full Year 2025 Guidance (Business Wire) +5.47%
Feb-19-25 04:05PM	KORU Medical Systems to Report Fourth Quarter and Full Year 2024 Financial Results on March 12, 2025 (Business Wire)
Feb-14-25 01:01PM	Piper Sandler Downgrades Koru Medical, Citing Valuation Concerns (GuruFocus.com) -8.00%
Feb-06-25 04:05PM	KORU Medical Systems Announces Agreement for Next-Generation Subcutaneous Immunoglobulin Infusion System (Business Wire)
Jan-30-25 04:05PM	KORU Medical Systems Announces Phase III Clinical Trial Collaboration for a New Drug Indication in Nephrology (Business Wire)
Jan-14-25 04:06PM	KORU Medical Systems Reports Preliminary Fourth Quarter and Full Year 2024 Results; Achieves Record Full Year and Quarterly Revenues; Positive Cash Flow for the Fourth Quarter (Business Wire)
Nov-25-24 04:05PM	KORU Medical Systems to Participate in Piper Sandler's 36th Annual Healthcare Conference (Business Wire)
Nov-15-24 07:16AM	Koru Medical price target raised to $4 from $3 at Canaccord (TipRanks)
Nov-14-24 02:16AM	KORU Medical Systems Inc (KRMD) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and ... (GuruFocus.com)
Nov-13-24 04:05PM	KORU Medical Systems, Inc. Announces 2024 Q3 Financial Results, Third Consecutive Quarter of Double-Digit Growth; Raises Full Year 2024 Guidance (Business Wire) +7.74%
Nov-06-24 04:05PM	KORU Medical Systems to Participate in Upcoming Investor Conferences (Business Wire)
Oct-31-24 04:03PM	KORU Medical Systems Presents Data at Partnership Opportunities in Drug Delivery (PODD) Conference Demonstrating Nursing Preference for Use of KORU FreedomEdge Infusion System over Manual Syringe Administration for Subcutaneous Oncology Infusion (Business Wire) +11.03% -7.53%
Oct-23-24 04:05PM	KORU Medical Systems to Report Third Quarter 2024 Financial Results on November 13, 2024 (Business Wire)
Oct-09-24 05:19PM	KORU Medical Systems Inc (KRMD) Q2 2024 Earnings Call Highlights: Record Revenue Growth and ... (GuruFocus.com) +6.20%
Sep-05-24 07:00AM	KORU Medical Systems to Participate in the 8th Annual Lake Street Best Ideas Growth Conference (Business Wire)
Aug-07-24 04:05PM	KORU Medical Systems, Inc. Announces 2024 Q2 Financial Results, a Record Quarter With 22% Revenue Growth; Raises Full Year 2024 Guidance (Business Wire) +16.43%
Jul-25-24 04:05PM	KORU Medical Systems to Participate in the Canaccord Genuity 44th Annual Growth Conference (Business Wire)
Jul-24-24 04:05PM	KORU Medical Systems, Inc Announces Leadership Changes to Support Growth Agenda (Business Wire)
Jul-17-24 04:05PM	KORU Medical Systems to Report Second Quarter 2024 Financial Results on August 7, 2024 (Business Wire)
Jul-03-24 12:27PM	KORU Medical's (KRMD) FreedomEdge Gets Regulatory Nod in Japan (Zacks) +11.89%
Jul-02-24 07:00AM	KORU Medical Systems Receives Regulatory Clearance for FreedomEdge Infusion System in Japan (Business Wire)
Jun-05-24 09:00AM	Simplifying Subcutaneous Drug Administration: SCHOTT Pharma and KORU Medical Systems Announce Collaboration to Advance Large Volume Subcutaneous Infusion (Business Wire)
Jun-04-24 04:03PM	KORU Medical Systems Announces a New Feasibility Study with a Commercialized Oncology Biologic (Business Wire)
May-14-24 04:05PM	KORU Medical Systems Signs Supply Agreement for a Phase III Clinical Trial for a Novel Endocrinological Biologic (Business Wire)
May-02-24 10:29AM	KORU Medical Systems, Inc. (NASDAQ:KRMD) Q1 2024 Earnings Call Transcript (Insider Monkey) +5.78%
03:39AM	KORU Medical Systems Inc (KRMD) Q1 2024 Earnings Call Transcript Highlights: Record Revenue and ... (GuruFocus.com)
May-01-24 06:06PM	KORU Medical Systems Inc (KRMD) Q1 2024 Earnings: Revenue Surpasses Estimates Amidst Challenges (GuruFocus.com)
04:05PM	KORU Medical Systems, Inc. Announces 2024 First Quarter Financial Results Delivering Double-Digit Revenue Growth (Business Wire)
Apr-17-24 07:00AM	KORU Medical Systems to Report First Quarter 2024 Financial Results on May 1, 2024 (Business Wire)
Apr-11-24 04:05PM	KORU Medical Systems Announces Successful Appeal in EU Notified Body Review (Business Wire) -6.73%
Mar-18-24 05:24PM	KORU Medical Systems to Present Data Demonstrating 97% Adherence on Its Freedom Infusion System for Large Volume Subcutaneous Administration at NHIA 2024 Conference (Business Wire) -5.45%
Mar-13-24 04:05PM	KORU Medical Systems, Inc. Announces 2023 Fourth Quarter, Full Year Financial Results, and 2024 Guidance (Business Wire)
Mar-12-24 08:22AM	KORU Medical (KRMD) Forms New Deal on Subcutaneous Infusion (Zacks)
Mar-11-24 04:05PM	KORU Medical Systems Announces a Feasibility Study to Enter Ambulatory Infusion Settings with a Commercialized Biologic (Business Wire)
Mar-06-24 07:00AM	KORU Medical Systems Signs a Clinical Supply Agreement for Phase 3 Trial with Leading Pharma Partner Using Custom Device for a Novel Subcutaneous Immunoglobulin (Business Wire) +5.39%
Feb-21-24 07:00AM	KORU Medical Systems to Report Fourth Quarter and Full Year 2023 Financial Results on March 13, 2024 (Business Wire)
Nov-29-23 07:00AM	KORU Medical Systems to Participate in Piper Sandlers 35th Annual Healthcare Conference (Business Wire)
Nov-28-23 08:00AM	KORU Medical Systems, Inc. to Host Investor Day on December 5, 2023 (Business Wire)
Nov-09-23 10:04AM	KORU Medical Systems, Inc. (NASDAQ:KRMD) Q3 2023 Earnings Call Transcript (Insider Monkey) -7.31%
Nov-08-23 06:11PM	KORU Medical Systems Inc (KRMD) Reports Q3 2023 Financial Results and Updates Full Year Outlook (GuruFocus.com) -5.19%
04:10PM	KORU Medical Systems, Inc. Announces Development Agreement for Next-generation Subcutaneous Immunoglobulin Infusion System (Business Wire)
04:08PM	KORU Medical Systems, Inc. Appoints Ken Miller as Chief Commercial Officer (Business Wire)
04:05PM	KORU Medical Systems, Inc. Announces 2023 Third Quarter Financial Results and Updates Full Year 2023 Outlook (Business Wire)
Nov-07-23 04:05PM	KORU Medical Systems, Inc. Receives FDA 510(k) Clearance for FREEDOM60 Infusion System With Hizentra 50 ML Prefilled Syringes (Business Wire)
Nov-02-23 04:05PM	KORU Medical Systems to Participate in Upcoming Investor Conferences (Business Wire)
Oct-25-23 04:05PM	KORU Medical Systems to Report Third Quarter Financial Results on November 8, 2023 (Business Wire)
Oct-05-23 07:05AM	KORU Medical Systems to Present Two Abstracts at the Immunoglobulin National Society 2023 National Conference (Business Wire)
Oct-04-23 04:05PM	KORU Medical Systems, Inc. Announces Appointment of Edward Wholihan to Its Board of Directors (Business Wire)

KORU Medical Systems, Inc. engages in the design, manufacture, and market of proprietary medical devices. Its product portfolio includes FREEDOM60, FreedomEdge syringe drivers, Precision Flow Rate Tubing, and HIgH-Flo Subcutaneous Safety Needle Sets. The company was founded by Andrew I. Sealfon and Adrian W. Zorgniotti on March 24, 1980 and is headquartered in Mahwah, NJ.

Insider Trading	Relationship	Date	Transaction	#Shares	#Shares Total	SEC Form 4
Pazdan Christopher	Chief Operating Officer	Mar 16 '26	Option Exercise	5,064	5,064	Mar 18 04:47 PM
Adams Thomas Edward	Chief Financial Officer	Mar 16 '26	Option Exercise	5,404	5,404	Mar 18 04:45 PM
Tharby Linda M	Chief Executive Officer	Mar 16 '26	Option Exercise	15,968	15,968	Mar 18 04:42 PM

STIM

Neuronetics Inc

KRMD

KORU Medical Systems Inc

Upgrade your Finviz experience